Dec 02, 2014 at 13:11 | Source: CNBC-TV18
Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today. We have Bharat Electronics (BEL), Pipavav Defence, Astra Micro, Sun Pharma Advanced Research Company (SPARC), Gujarat Pipavav and Bajaj Auto.
Dec 02, 2014 at 08:43 | Source: CNBC-TV18
Here are Top 10 stocks to focus on December 2 - Strides Arcolab, Mindtree, PNB, Yes Bank, Tata Motors, Hero Moto, Sparc, Gokaldas Exports, IRB Infra and Dr Reddy's.
Dec 02, 2014 at 08:34 | Source: Moneycontrol.com
Sun Pharma Advanced Research Company announced that the US Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for Latanoprost BAK-free eyedrops.
Nov 05, 2014 at 09:07 | Source: Moneycontrol.com
Infosys announced that the Finacle Payment Solution running on Oracle SPARC T5 servers with Oracle Solaris 11.2 has set a new global benchmark for the volume of inter-bank payment transactions processed.
Sep 30, 2014 at 22:41 | Source: Moneycontrol.com
Sparc Systems in its meeting held on September 30, 2014, inter alia, has appointed Ms. Geeta Salekar as CFO of the Company with immediate effect.
Jul 31, 2014 at 20:42 | Source: PTI
Total income of the company during the April-June quarter declined marginally to Rs 35.85 crore. It was Rs 35.67 crore in the same period of the last fiscal.
May 05, 2014 at 10:24 | Source: Moneycontrol.com
The total income of the company declined to Rs 42.57 crore during the first quarter, as compared to Rs 71.83 crore in the same period of previous fiscal.
May 05, 2014 at 10:07 | Source: PTI
The total income of the company declined to Rs. 42.57 crore during the first quarter, as compared to Rs. 71.83 crore in the same period of previous fiscal.
May 05, 2014 at 08:53 | Source: CNBC-TV18
Following are the top 10 stocks to keep a watch on BPCL, Indiabulls Real, ABB, Suzlon, Tata Motors, Ashok Leyland, Sparc, Rel Comm, Future Lifestyle, V-Guard
Feb 28, 2014 at 09:29 | Source: Moneycontrol.com
The key drug which is to be studied for epilepsy is Levetiracetam ER. The estimated peak sales at USD 35-50 million and it may be approved by FY16.